IL314952A - Pharmaceutical preparation containing diphenyldiazole history and methods of use - Google Patents

Pharmaceutical preparation containing diphenyldiazole history and methods of use

Info

Publication number
IL314952A
IL314952A IL314952A IL31495224A IL314952A IL 314952 A IL314952 A IL 314952A IL 314952 A IL314952 A IL 314952A IL 31495224 A IL31495224 A IL 31495224A IL 314952 A IL314952 A IL 314952A
Authority
IL
Israel
Prior art keywords
diphenyldiazole
derivatives
methods
pharmaceutical composition
pharmaceutical
Prior art date
Application number
IL314952A
Other languages
English (en)
Hebrew (he)
Original Assignee
Modag Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modag Gmbh filed Critical Modag Gmbh
Publication of IL314952A publication Critical patent/IL314952A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL314952A 2022-03-01 2023-03-01 Pharmaceutical preparation containing diphenyldiazole history and methods of use IL314952A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22159408 2022-03-01
PCT/EP2023/055160 WO2023166045A1 (en) 2022-03-01 2023-03-01 Pharmaceutical composition comprising diphenyldiazole derivatives and methods of use

Publications (1)

Publication Number Publication Date
IL314952A true IL314952A (en) 2024-10-01

Family

ID=80623476

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314952A IL314952A (en) 2022-03-01 2023-03-01 Pharmaceutical preparation containing diphenyldiazole history and methods of use

Country Status (12)

Country Link
US (1) US20250161273A1 (cg-RX-API-DMAC7.html)
EP (1) EP4486340A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025508912A (cg-RX-API-DMAC7.html)
KR (1) KR20240155237A (cg-RX-API-DMAC7.html)
CN (1) CN118715010A (cg-RX-API-DMAC7.html)
AU (1) AU2023227368A1 (cg-RX-API-DMAC7.html)
CA (1) CA3246018A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002379A1 (cg-RX-API-DMAC7.html)
IL (1) IL314952A (cg-RX-API-DMAC7.html)
MX (1) MX2024009773A (cg-RX-API-DMAC7.html)
PE (1) PE20250781A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023166045A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024349468A1 (en) 2023-09-26 2026-04-16 Teva Pharmaceutical Industries Ltd. Emrusolmin for use in treating multiple system atrophy
KR20250090047A (ko) * 2023-12-12 2025-06-19 가천대학교 산학협력단 긴 탄소사슬을 포함하는 리파펜틴, 암포테리신 b, 세틸피리디늄, 도미펜, 토코페르솔란을 유효성분으로 포함하는 시누클레인병증 치료용 약제학적 조성물
WO2026139903A1 (en) 2024-12-23 2026-07-02 Teva Pharmaceutical Industries Ltd. Solid state forms of emrusolmin and process for preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2714453T3 (es) * 2008-06-09 2019-05-28 Univ Muenchen Ludwig Maximilians Fármacos para inhibir la agregación de proteínas implicadas en enfermedades relacionadas con enfermedades neurodegenerativas y/o agregación de proteínas
KR102671166B1 (ko) * 2015-12-14 2024-05-31 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. 3,5-디페닐-디아졸 화합물의 수용성 유도체

Also Published As

Publication number Publication date
KR20240155237A (ko) 2024-10-28
EP4486340A1 (en) 2025-01-08
AU2023227368A1 (en) 2024-07-18
CN118715010A (zh) 2024-09-27
US20250161273A1 (en) 2025-05-22
JP2025508912A (ja) 2025-04-10
WO2023166045A1 (en) 2023-09-07
PE20250781A1 (es) 2025-03-14
CL2024002379A1 (es) 2025-01-24
CA3246018A1 (en) 2023-09-07
MX2024009773A (es) 2024-08-19

Similar Documents

Publication Publication Date Title
IL304680A (en) Urolithin history and methods of using them
IL316049A (en) Musuntuzumab pharmaceutical preparations and methods of use
IL316170A (en) Pharmaceutical compositions of therapeutic proteins and methods of use
IL315862A (en) Angiotensinogen modulators and methods of using them
GB2622995B (en) CAS13-based compositions and methods of use thereof
IL311733A (en) Hydrochloride salt of inupdanant, pharmaceutical preparations and methods of using it
EP4168033A4 (en) CEBP-BETA ANTAGONIST ADMINISTRATION AND METHODS OF USE
IL316562A (en) High-dose and convenient formulations of endoxifen
IL319382A (en) Pharmaceutical preparation and its use
IL320437A (en) Crystalline forms, pharmaceutical preparations and methods of using them
EP3747896A4 (en) PHARMACEUTICAL COMPOSITION OF ACYLATED DERIVATIVE OF HUMAN INSULIN ANALOGUE AND MANUFACTURING PROCESS FOR IT
SI4554562T1 (sl) Sestavki olanzapina in postopki njihove uporabe
EP4349339A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER AND ITS USE
HK40121460A (en) Pharmaceutical compositions of mosunetuzumab and methods of use
IL319100A (en) Pharmaceutical preparation and method for using it
CA3281828A1 (en) Combined pharmaceutical composition of substituted 2-hydrogen-pyrazole derivative and use thereof
HK40130528A (en) Combined pharmaceutical composition of substituted 2-hydrogen-pyrazole derivative and use thereof
PL4531816T3 (pl) Formulacje farmaceutyczne biktegrawiru oraz lenakapawiru
HK40073538A (en) Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivatives
CA3273991A1 (en) Equine-specific therapeutic compositions and methods of use
IL314496A (en) A pharmaceutical preparation of an antibody directed against TRBV9 and its use
GB202110139D0 (en) Performance-tuned formulations of piperonly derivatives and methods for their preparation
ZA202102092B (en) Pharmaceutical composition comprising rivaroxaban and method of preparation thereof
IL325884A (en) Gal475 compositions and methods of use thereof
HK40103407A (en) Urolithin derivatives and methods of use thereof